Novartis has reported a decline in net income for its 2008 year-end financial results, despite a 70 percent increase in net income for the 2008 fiscal fourth quarter.

Medtronic has expanded its CURE-AF [atrial fibrillation] SM clinical program with a post-market study in Europe and Canada.

BOSTONHansen Medical showcased its Sensei Robotic Catheter System and the CoHesion 3D visualization module at the 14th annual Boston Atrial Fibrillation Symposium (BAFS), Jan. 15-17.

The prevailing notion is that bypass surgery is superior to stenting in patients with diabetes. The truth, however, is more complicated, as the decision-makers learn to examine the individual pathologies in lieu of standardization. Often, this process is more art than science in taking into account all of the parameters of a patients disease.

Recent studies suggest the staggering clinical and economic costs of critical limb ischemia can be reduced by utilizing newer treatment technologies.

Analysts forecast an increase in the number of heart failure patients, going from 6 million in 2007 to more than 30 million in 2037. This rapidly expanding patient population will challenge cardiologists, allied health personnel and equipment and device manufacturers to keep pace with ever-changing ways to improve care and survival rates.

Cardiovascular Business invited some of the most prominent physicians in the field of electrophysiology to talk about the current and future state of the subspecialty.

The use of advanced visualization software enables interpreting clinicians to determine the distribution of growth rates across different sizes and subtypes of renal cortical tumors, according to a study published in the January issue of Radiology.